ARCHIVES

White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis

This article is from The Cancer Letter archive.

Vol. 03 No. 29 | July 22, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

January 4, 1991

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

Hoogstraten Resignation Sidetracks Kansas’ Move to Comprehensive Status, Threatens Core Grant

February 15, 1980

ANG1005 Demonstrates Activity In Patients with Brain Metastases

November 29, 2013